The role of antibodies in transplantation

Transplantation Reviews

Volumn 23, Issue 4, 2009, Pages 191-198

  Chang, Alexander T ^a   Platt, Jeffrey L ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C4D; HLA ANTIBODY;

ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CHRONIC GRAFT REJECTION; COMPLEMENT ACTIVATION; DISEASE PREDISPOSITION; GRAFT DYSFUNCTION; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; RISK FACTOR; TRANSPLANTATION;

EID: 70349175792     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2009.06.002     Document Type: Article

References (73)

1. Medawar P. Tests by tissue culture methods on the nature of immunity transplanted skin. Q J Microsc Sci s3-89 (1948) 239-252
2. Gorer P.A. The antigenic basis of tumour transplantation. J Path Bact 47 (1938) 231-252
3. Gorer P.A. Studies in antibody response of mice to tumour inoculation. Br J Cancer 4 (1950) 372-379
4. Woodruff M.F.A., and Allan T.M. Blood groups and the homograft problem. Brit J Plast Surg 5 (1953) 238-242
5. Medawar P.B. Immunity to homologous grafted skin: the relationship between the antigens of blood and skin. Brit J Exp Pathol 27 (1946) 15-24
6. Gibson T., and Medawar P.B. The fate of skin homografts in man. J Anat 77 (1943) 299-310
7. Takemoto S.K., Zeevi A., Feng S., et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transp 4 (2004) 1033-1041
8. Platt J.L. New directions for organ transplantation. Nature 392 (1998) 11-17
9. Nagata H., Ito M., Cai J., Edge A., Platt J.L., and Fox I.J. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology 124 (2003) 422-431
10. Platt J.L., and Fox I.J. Xenotransplantation and the liver. In: Busuttil R.W., and Klintmalm G.B. (Eds). Transplantation of the Liver. 2nd ed. (2005), Elsevier, Philadelphia 1365-1377
11. Kissmeyer-Nielsen F., Olsen S., Petersen V.P., and Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 2 (1966) 662-665
12. Patel R., and Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. New Eng J Med 280 (1969) 735-739
13. Gleason R.E., and Murray J.E. Report from kidney transplant registry: analysis of variables in the function of human kidney transplants. Transplantation 5 (1967) 343-359
14. Brynger H., Rydberg L., Samuelsson B.E., and Sandberg L. Experience with 14 renal transplants with kidneys from blood group A (subgroup A2) to O recipients. Transplant Proc 16 (1984) 1175
15. Starzl T.E., Putnam C.W., Porter K.A., et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 6 (1974) 129-139
16. Gordon R.D., Iwatsuki S., Esquivel C.O., Tzakis A., Todo S., and Starzl T.E. Liver transplantation across ABO blood groups. Surgery 100 (1986) 342-348
17. Collins B.H., Chari R.S., Magee J.C., et al. Mechanisms of injury in porcine livers perfused with blood of humans with fulminant hepatic failure. Transplantation 58 (1994) 1162-1171
18. Koch C.A., Kanazawa A., Nishitai R., et al. Intrinsic resistance of hepatocytes to complement-mediated injury. J Immunol 174 (2005) 7302-7309
19. Tzou P., De Gregorio E., and Lemaitre B. How Drosophila combats microbial infection: a model to study innate immunity and host-pathogen interactions. Curr Opin Microbiol 5 (2002) 102-110
20. Kalil J., Guilherme L., Nuemann J., et al. Humoral rejection in two HLA identical living related donor kidney transplants. Transplant Proc 21 (1989) 711-713
21. Platt J.L., Vercellotti G.M., Dalmasso A.P., et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 11 (1990) 450-456
22. Brauer R.B., Baldwin III W.M., Daha M.R., Pruitt S.K., and Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 151 (1993) 7240-7248
23. Gewurz H., Clark D.S., Cooper M.D., Varco R.L., and Good R.A. Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions. Transplantation 5 (1967) 1296-1303
24. Pruitt S.K., Kirk A.D., Bollinger R.R., et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57 (1994) 363-370
25. McCurry K.R., Kooyman D.L., Alvarado C.G., et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1 (1995) 423-427
26. Miyagawa S., Hirose H., Shirakura R., et al. The mechanism of discordant xenograft rejection. Transplantation 46 (1988) 825-830
27. Dalmasso A.P., Vercellotti G.M., Fischel R.J., Bolman R.M., Bach, and Platt J.L. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 140 (1992) 1157-1166
28. Devine D., and Rosse W. Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc Natl Acad Sci USA 84 (1987) 5873-5877
29. Colvin R., and Smith R. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5 (2005) 807-817
30. Vakeva A.P., Agah A., Rollins S.A., Matis L.A., Li L., and Stahl G.L. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97 (1998) 2259-2267
31. Zhou W., Farrar C.A., Abe K., et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105 (2000) 1363-1371
32. Spector D., Limas C., Frost J.L., et al. Perfusion nephropathy in human transplants. New Eng J Med 295 (1976) 1217-1221
33. Cerra F.B., Raza S., Andres G.A., and Siegel J.H. The endothelial damage of pulsatile renal preservation and its relationship to perfusion pressure and colloid osmotic pressure. Surgery 81 (1977) 534-541
34. Saadi S., and Platt J.L. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 181 (1995) 21-31
35. Platt J.L. Antibodies in graft rejection. In: Bach F.H., and Auchincloss H. (Eds). Transplantation Immunology (1995), Wiley-Liss, Inc., New York City (NY) 113-129
36. Solez K., Colvin R.B., Racusen L.C., et al. Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7 (2007) 518-526
37. Bustos M., Saadi S., and Platt J.L. Platelet-mediated activation of endothelial cells: implications for the pathogenesis of transplant rejection. Transplantation 72 (2001) 509-515
38. Mauiyyedi S., and Colvin R. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 11 (2002) 609-618
39. Parker W., Lin S.S., and Platt J.L. Antigen expression in xenotransplantation: how low must it go?. Transplantation 71 (2001) 313-319
40. Feucht H.E., Felber E., Gokel M.J., et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 86 (1991) 464-470
41. Collins A.B., Schneeberger E.E., Pascual M.A., et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 10 (1999) 2208-2214
42. Platt J.L. C4d and the fate of organ allografts. J Am Soc Nephrol 13 (2002) 2417-2419
43. Miyata Y., and Platt J.L. The role of complement in acute vascular rejection: lessons from the inhibition of C1rs activity. Transplantation 73 (2002) 675
44. Marcum J.A., and Rosenberg R.D. Anticoagulantly active heparan sulfate proteoglycan and the vascular endothelium. Semin Thromb Hemost 13 (1987) 464-474
45. Ihrcke N.S., Wrenshall L.E., Lindman B.J., and Platt J.L. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today 14 (1993) 500-505
46. Saadi S., Holzknecht R.A., Patte C.P., Stern D.M., and Platt J.L. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 182 (1995) 1807-1814
47. Saadi S., and Platt J.L. Endothelial cell responses to complement activation. In: Volanakis J.E., and Frank M.M. (Eds). The human complement system in health and disease (1998), Marcel Dekker, Inc., New York 335-353
48. Saadi S., Wrenshall L.E., and Platt J.L. Regional manifestations and control of the immune system. FASEB J 16 (2002) 849-856
49. Saadi S., Takahashi T., Holzknecht R.A., and Platt J.L. Pathways to acute humoral rejection. Am J Pathol 164 (2004) 1073-1080
50. Brunn G.J., Saadi S., and Platt J.L. Differential regulation of endothelial cell activation by complement and interleukin 1alpha. Circ Res 98 (2006) 793-800
51. Brunn G.J., Saadi S., and Platt J.L. Constitutive repression of IL-1alpha in endothelial cells. Circ Res 102 (2008) 823-830
52. Bannett A.D., McAlack R.F., Raja R., Baquero A., and Morris M. Experiences with known ABO- mismatched renal transplants. Transplant Proc 19 (1987) 4543-4546
53. Bannett A.D., McAlack R.F., Morris M., Chopek M., and Platt J.L. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc 21 (1989) 783-785
54. Koch C.A., Khalpey Z.I., and Platt J.L. Accommodation: preventing injury in transplantation and disease. J Immunol 172 (2004) 5143-5148
55. Alexandre G.P.J., Squifflet J.P., De Bruyere M., et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 17 (1985) 138-143
56. Chopek M.W., Simmons R.L., and Platt J.L. ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc 19 (1987) 4553-4557
57. Tang A.H., and Platt J.L. Accommodation of grafts: implications for health and disease. Hum Immunol 68 (2007) 645-651
58. Cozzi E., Yannoutsos N., Langford G.A., Pino-Chavez G., Wallwork J., and White D.J.G. Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. In: Cooper D.K.C., Kemp E., Platt J.L., and White D.J.G. (Eds). Xenotransplantation: the transplantation of organs and tissues between species. 2nd ed (1997), Springer, Berlin 665-682
59. Lin S.S., Weidner B.C., Byrne G.W., et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 101 (1998) 1745-1756
60. Nath K.A., Balla G., Vercellotti G.M., et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90 (1992) 267-270
61. Bach F.H., Ferran C., Hechenleitner P., et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3 (1997) 196-204
62. Hancock W.W., Buelow R., Sayegh M.H., and Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 4 (1998) 1392-1396
63. Delikouras A., Fairbanks L.D., Simmonds A.H., Lechler R.I., and Dorling A. Endothelial cell cytoprotection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors. Eur J Immunol 33 (2003) 3127-3135
64. Jindra P.T., Zhang X., Mulder A., et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 82 (2006) S33-S35
65. Park W., Grande J.P., Ninova D., et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 3 (2003) 952-960
66. Williams J.M., Holzknecht Z.E., Plummer T.B., Lin S.S., Brunn G.J., and Platt J.L. Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. Transplantation 78 (2004) 1471-1478
67. Waltenberger J., Wanders A., Fellstrom B., Miyazono K., Heldin C.H.., and Funa K. Induction of transforming growth factor-b during cardiac allograft rejection. J Immunol 151 (1993) 1147-1157
68. Mauiyyedi S., Pelle P., Saidman S., et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12 (2001) 574-582
69. Piazza A., Poggi E., Borrelli L., et al. Impact of donor- specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation 71 (2001) 1106-1112
70. Lee P., Terasaki P., Takemoto S., et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74 (2002) 1192
71. Lederer S., Kluth-Pepper B., Schneeberger H., Albert E., Land W., and Feucht H. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 59 (2001) 334-341
72. Regele H., Bohmig G.A., Habicht A., et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 13 (2002) 2371-2380
73. Platt J.L., and Nath K.A. Heme oxygenase: protective gene or Trojan horse. Nat Med 4 (1998) 1364-1365